Institute of Experimental Medicine is conducting preclinical studies on the world's first yogurt-based COVID-19 vaccine with Ryazhenka flavor.
Alexander Suvorov, the head of the department of molecular microbiology of the institute, said that a fragment of the synthesized genome of the COVID-19 is injected into the bacterium's genome while creating the vaccine. Due to the genetic modification, the bacterium produces the COVID-19 protein, which develops an immune response.
Lab animals such as mice and rats displayed an extreme immune response with no side effects. Suvorov noted that vaccine development continues to be studied in laboratory animals and is waiting for the chance of investigating protection. Only after that will it be possible to send the vaccine for studies. So, the vaccine's effectiveness against the live virus, on the other hand, has yet to be confirmed. The research is expected to be completed by the end of 2021 or by early 2022.
The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.